| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |